270 related articles for article (PubMed ID: 31936103)
1. Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles.
AbouAitah K; Hassan HA; Swiderska-Sroda A; Gohar L; Shaker OG; Wojnarowicz J; Opalinska A; Smalc-Koziorowska J; Gierlotka S; Lojkowski W
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936103
[TBL] [Abstract][Full Text] [Related]
2. Co-Delivery System of Curcumin and Colchicine Using Functionalized Mesoporous Silica Nanoparticles Promotes Anticancer and Apoptosis Effects.
AbouAitah K; Soliman AAF; Swiderska-Sroda A; Nassrallah A; Smalc-Koziorowska J; Gierlotka S; Lojkowski W
Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559264
[TBL] [Abstract][Full Text] [Related]
3. Etoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution.
Saroj S; Rajput SJ
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1115-S1130. PubMed ID: 30669865
[TBL] [Abstract][Full Text] [Related]
4. Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action.
AbouAitah K; Swiderska-Sroda A; Farghali AA; Wojnarowicz J; Stefanek A; Gierlotka S; Opalinska A; Allayeh AK; Ciach T; Lojkowski W
Oncotarget; 2018 May; 9(41):26466-26490. PubMed ID: 29899871
[TBL] [Abstract][Full Text] [Related]
5. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
6. Nanofabrication of PLGA-PEG-chitosan-folic acid systems for delivery of colchicine to HT-29 cancer cells.
Sadeghzadeh F; Ziaratnia AS; Homayouni Tabrizi M; Torshizi GH; Alhajamee M; Khademi D
J Biomater Sci Polym Ed; 2023 Jan; 34(1):1-17. PubMed ID: 35864733
[TBL] [Abstract][Full Text] [Related]
7. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
[TBL] [Abstract][Full Text] [Related]
8. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
9. Effective Targeting of Colon Cancer Cells with Piperine Natural Anticancer Prodrug Using Functionalized Clusters of Hydroxyapatite Nanoparticles.
AbouAitah K; Stefanek A; Higazy IM; Janczewska M; Swiderska-Sroda A; Chodara A; Wojnarowicz J; Szałaj U; Shahein SA; Aboul-Enein AM; Abou-Elella F; Gierlotka S; Ciach T; Lojkowski W
Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31963155
[TBL] [Abstract][Full Text] [Related]
10. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release.
Shahein SA; Aboul-Enein AM; Higazy IM; Abou-Elella F; Lojkowski W; Ahmed ER; Mousa SA; AbouAitah K
Int J Nanomedicine; 2019; 14():5503-5526. PubMed ID: 31410001
[TBL] [Abstract][Full Text] [Related]
11. siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cells.
Heidari R; Khosravian P; Mirzaei SA; Elahian F
Sci Rep; 2021 Oct; 11(1):20531. PubMed ID: 34654836
[TBL] [Abstract][Full Text] [Related]
12. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
[TBL] [Abstract][Full Text] [Related]
13. Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery.
Al-Nadaf AH; Dahabiyeh LA; Jawarneh S; Bardaweel S; Mahmoud NN
Pharm Dev Technol; 2021 Jun; 26(5):582-591. PubMed ID: 33729906
[TBL] [Abstract][Full Text] [Related]
14. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC).
Song Y; Zhou B; Du X; Wang Y; Zhang J; Ai Y; Xia Z; Zhao G
Biomed Pharmacother; 2020 May; 125():109561. PubMed ID: 32106385
[TBL] [Abstract][Full Text] [Related]
15. Matrix Metalloproteinase-Responsive Mesoporous Silica Nanoparticles Cloaked with Cleavable Protein for "Self-Actuating" On-Demand Controlled Drug Delivery for Cancer Therapy.
Vaghasiya K; Ray E; Sharma A; Katare OP; Verma RK
ACS Appl Bio Mater; 2020 Aug; 3(8):4987-4999. PubMed ID: 35021676
[TBL] [Abstract][Full Text] [Related]
16. Preparation of RGD Peptide/Folate Acid Double-Targeted Mesoporous Silica Nanoparticles and Its Application in Human Breast Cancer MCF-7 Cells.
Yan H; You Y; Li X; Liu L; Guo F; Zhang Q; Liu D; Tong Y; Ding S; Wang J
Front Pharmacol; 2020; 11():898. PubMed ID: 32612532
[TBL] [Abstract][Full Text] [Related]
17. Controlled synthesis and size effects of multifunctional mesoporous silica nanosystem for precise cancer therapy.
Ma B; He L; You Y; Mo J; Chen T
Drug Deliv; 2018 Nov; 25(1):293-306. PubMed ID: 29334793
[TBL] [Abstract][Full Text] [Related]
18. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC
Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-coated Zn-metal-organic framework nanocomposites for effective targeted delivery of LNA-antisense miR-224 to colon tumor: in vitro studies.
Mokri N; Sepehri Z; Faninam F; Khaleghi S; Kazemi NM; Hashemi M
Gene Ther; 2022 Dec; 29(12):680-690. PubMed ID: 34108628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
